Quadrature Capital LTD Alvotech Transaction History
Quadrature Capital LTD
- $8.45 Trillion
- Q3 2025
A detailed history of Quadrature Capital LTD transactions in Alvotech stock. As of the latest transaction made, Quadrature Capital LTD holds 22,729 shares of ALVO stock, worth $124,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,729Holding current value
$124,782% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALVO
# of Institutions
65Shares Held
15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.35MShares$23.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$14.9 Million12.58% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$8.58 Million0.33% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.45MShares$7.98 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$7.24 Million12.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $1.37B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...